Wells Fargo’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
Wells Fargo's MXCT Position: Q2 2026 in Review
Wells Fargo sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 38,214 shares — an estimated $26.8K sold.
Wells Fargo first reported a position in MXCT in Q3 2021 and held it in 19 quarters. The position peaked at $2.29M in Q3 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- Wells Fargo reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
- Wells Fargo sold 38,214 MaxCyte shares in Q2 2026, an estimated $26.8K.
- Wells Fargo first reported a position in MaxCyte in Q3 2021 and held it in 19 quarters.
- Wells Fargo's MaxCyte position peaked at $2.29M in Q3 2021.
- 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.